NMDA?1/2 (phospho Tyr1246/1252) Polyclonal Antibody


NMDA?1/2 (phospho Tyr1246/1252) Polyclonal Antibody

Cat No.:HR1AP6763
Product available

  Product info

Alternative Name: GRIN2A; NMDAR2A; Glutamate [NMDA] receptor subunit epsilon-1; N-methyl D-aspartate receptor subtype 2A; NMDAR2A; NR2A; hNR2A; GRIN2B; NMDAR2B; Glutamate [NMDA] receptor subunit epsilon-2; N-methyl D-a

Antibodies Type: polyclonal



Product Details

Product Name NMDA?1/2 (phospho Tyr1246/1252) Polyclonal Antibody
Cat NumberHR1AP6763
SourceRabbit
ApplicationsIHC-p,IF,ELISA
Species Reactivity Human,Mouse,Rat
Storage -20°C/1 year
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration 1 mg/ml
Gene ID GRIN2A/GRIN2B
Alternative Name GRIN2A; NMDAR2A; Glutamate [NMDA] receptor subunit epsilon-1; N-methyl D-aspartate receptor subtype 2A; NMDAR2A; NR2A; hNR2A; GRIN2B; NMDAR2B; Glutamate [NMDA] receptor subunit epsilon-2; N-methyl D-a
Background glutamate ionotropic receptor NMDA type subunit 2A(GRIN2A) Homo sapiens This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without mental retardation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014],
Type polyclonal

Write us

Superfast Delivery
Customer Support
Secure Online Payment